lapatinib has been researched along with phenol in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (phenol) | Trials (phenol) | Recent Studies (post-2010) (phenol) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 6,571 | 101 | 2,591 |
| Protein | Taxonomy | lapatinib (IC50) | phenol (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 4.63 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 4.63 | |
| Carbonic anhydrase 6 | Homo sapiens (human) | 4.63 | |
| Carbonic anhydrase 3 | Bos taurus (cattle) | 4.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianca, D; Caro, G; Fabbrocini, G; Panariello, L | 1 |
1 other study(ies) available for lapatinib and phenol
| Article | Year |
|---|---|
Phenol 8% solution for the treatment of epidermal growth factor receptor inhibitor-induced periungual pyogenic granulomas.
Topics: Administration, Topical; Antineoplastic Agents; Breast Neoplasms; Caustics; Cautery; ErbB Receptors; Female; Granuloma, Pyogenic; Humans; Lapatinib; Middle Aged; Nail Diseases; Neoplasm Proteins; Phenol; Protein Kinase Inhibitors; Quinazolines; Toes | 2015 |